ASTX660

Item number	Size	Delivery time	Price
TGM-TQ0029-1mg	1 mg	7 - 10 business days*	75.00€
TGM-TQ0029-5mg	5 mg	7 - 10 business days*	145.00€
TGM-TQ0029-1mL	1 ml	7 - 10 business days*	175.00€
TGM-TQ0029-10mg	10 mg	7 - 10 business days*	228.00€
TGM-TQ0029-25mg	25 mg	7 - 10 business days*	453.00€
TGM-TQ0029-50mg	50 mg	7 - 10 business days*	671.00€
TGM-TQ0029-100mg	100 mg	7 - 10 business days*	956.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: ASTX660 is an orally bioavailable dual antagonist of cIAP (cellular inhibitor of... more

Close menu

Product information "ASTX660"

Description: ASTX660 is an orally bioavailable dual antagonist of cIAP (cellular inhibitor of apoptosis protein) and XIAP (X-linked inhibitor of apoptosis protein). Target: IAP. Smiles: C[C@@H]1CN(CC(=O)N2CC(C)(C)c3nc(CO)c(Cc4ccc(F)cc4)cc23)[C@@H](CN2CCOC[C@H]2C)CN1. References: Tomoko Smyth, et al. Abstract 1287: The dual IAP antagonist, ASTX660, increases the anti-tumor activity of paclitaxel in preclinical models of triple-negative breast cancer in vivo. Cancer Res 2016,76(14 Suppl).

Supplier:	TargetMol
Supplier-Nr:	TQ0029

Properties

Application:	IAP protein-peptide interaction non-peptidomimetic inhibitor
MW:	539.68 D
Formula:	C30H42FN5O3

Database Information

CAS :	1799328-86-1\| Matching products
KEGG ID :	K04725 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "ASTX660"

Write a review